Publicacions en què col·labora amb Jordi Llop Roig (37)

2024

  1. Multimodal imaging of the role of hyperglycemia following experimental subarachnoid hemorrhage

    Journal of Cerebral Blood Flow and Metabolism, Vol. 44, Núm. 5, pp. 726-741

  2. Urease-powered nanobots for radionuclide bladder cancer therapy

    Nature Nanotechnology, Vol. 19, Núm. 4, pp. 554-564

2023

  1. Assessment of Regional Lung Ventilation with Positron Emission Tomography Using the Radiofluorinated Gas [18F]SF6: Application to an Animal Model of Impaired Ventilation

    Molecular Imaging and Biology, Vol. 25, Núm. 2, pp. 413-422

  2. Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders

    Biomedicines, Vol. 11, Núm. 2

  3. Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 43, Núm. 8, pp. 1301-1316

2022

  1. Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

2021

  1. Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease

    Theranostics, Vol. 11, Núm. 13, pp. 6542-6559

  2. Opposite alterations of 5­HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile

    Translational Psychiatry, Vol. 11, Núm. 1

2020

  1. In vivo PET Imaging of Gliogenesis After Cerebral Ischemia in Rats

    Frontiers in Neuroscience, Vol. 14

  2. In vivo multimodal imaging of adenosine A1 receptors in neuroinflammation after experimental stroke

    Theranostics, Vol. 11, Núm. 1, pp. 410-425

2019

  1. Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1335-1344

  2. In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia

    GLIA, Vol. 66, Núm. 8, pp. 1611-1624

  3. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis

    EMBO Molecular Medicine, Vol. 10, Núm. 8

  4. PET Imaging of Crossed Cerebellar Diaschisis after Long-Term Cerebral Ischemia in Rats

    Contrast Media and Molecular Imaging, Vol. 2018

2017

  1. Evaluation of the novel TSPO radiotracer [18F] VUIIS1008 in a preclinical model of cerebral ischemia in rats

    EJNMMI Research, Vol. 7

  2. PET imaging of cannabinoid type 2 receptors with [ 11 C]A-836339 did not evidence changes following neuroinflammation in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 37, Núm. 3, pp. 1163-1178

2016

  1. In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, Núm. 6, pp. 1124-1138

  2. PET imaging with [18F]FSPG evidences the role of system xc- on brain inflammation following cerebral ischemia in rats

    Theranostics, Vol. 6, Núm. 11, pp. 1753-1767

2015

  1. Imaging the role of toll-like receptor 4 on cell proliferation and inflammation after cerebral ischemia by positron emission tomography

    Journal of Cerebral Blood Flow and Metabolism, Vol. 36, Núm. 4, pp. 702-708